- Country: Ukraine
- Summary: Laboratory Reagents for Clinical Trials, Nc 024: 2023: 53607-Alpha-1-Acid Glycoprotein (Orosomocoid) Ivd (Diagnosis in Vitro), Reagent; 53230 - Total Bilirubin Ivd (Diagnosis in Vitro ...
- UAT Ref No: 122807259
- Deadline: 24 Jul 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: UAH 480000
- Notice Type: Tender
- Document Ref. No.: UA-2025-07-16-002356-a
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Laboratory reagents for clinical trials, NC 024: 2023: 53607-alpha-1-acid glycoprotein (orosomocoid) IVD (diagnostics in vitro), reagent; 53230 - total bilirubin IVD (diagnosis in vitro), set, enzymatic spectrophotometric analysis; 43203 - set for carrying out Tymolova sample; 63234 -C-reactive protein (CRP) IVD (in vitro diagnosis), set, agglutination, express analysis; 55112 - IVD rheumatoid factor (in vitro diagnosis), set, agglutination reaction; 63271 - beta -hemolytic numerous group of streptococci streptolysin O, antibodies IVD (diagnosis in vitro), set, agglutination; 30593 - calcium chloride. Reagent for analyzing the formation of an IVD clot (in vitro diagnosis); 55997 - fibrinogen (factor I) IVD (diagnosis in vitro), set, analysis of clot formation; 42651 - buffer isotonic saline solution, IVD (diagnosis in vitro); 32449 - Treponema Pallidum Reagena Antibodies IVD (in vitro diagnosis), control material; 52647 - anti -Rh (D) Group Typing of Erythrocytes IVD (Diagnosis in Vitro), Antibodies; 52532 - anti -A group typing of erythrocytes IVD (diagnosis in vitro), antibodies; 52538 - anti -B group type of erythrocytes IVD (in vitro diagnosis), antibodies; 55866 - Calculation of blood cells IVD (diagnosis in vitro), control material; 58237 - buffer solvent of samples of IVD (diagnostics in vitro), automatic/ semi -automatic systems; 61165 - reagent for lysis of blood cells IVD (diagnosis in vitro); 52867 - Calculation of blood cells IVD (DIME ...
View Purchases: goods
DK 021: 2015: 33600000-6: Pharmaceutical products
Set of reagents for determining the content of seromucoids in serum 40 definitions, "bilirubin" - a set for determining the concentration of total and direct bilirubin in serum human blood (110 definitions) HP005.01, "Timoliv SPL -set of reagents for serum Timol sample 1000 ml, SRB latex-test, set of reagents for determining C-reactive serum protein (200 definitions), Russian Federation-Latex-Test, Set of Reagents for Determining Rheuma... - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINLaboratory Reagents for Clinical Trials, Nc 024: 2023: 53607-Alpha-1-Acid Glycoprotein (Orosomocoid) Ivd (Diagnosis in Vitro), Reagent; 53230 - Total Bilirubin Ivd (Diagnosis in Vitro ... - Ukraine Tender
The KALUSKA CITY HOSPITAL OF KALUGA CITY COUNCIL, a Government sector organization in Ukraine, has announced a new tender for Laboratory Reagents for Clinical Trials, Nc 024: 2023: 53607-Alpha-1-Acid Glycoprotein (Orosomocoid) Ivd (Diagnosis in Vitro), Reagent; 53230 - Total Bilirubin Ivd (Diagnosis in Vitro .... This tender is published on UkraineTenders under UAT Ref No: 122807259 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-07-24.
The estimated tender value is UAH 480000, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
